Centiva Capital’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.3K | Hold |
30,000
| – | – | ﹤0.01% | 1093 |
|
|
2025
Q1 | $66.3K | Buy |
+30,000
| New | +$66.3K | ﹤0.01% | 1237 |
|
|
2024
Q4 | – | Sell |
-25,000
| Closed | -$208K | – | 1656 |
|
|
2024
Q3 | $208K | Sell |
25,000
-21
| -0.1% | -$175 | ﹤0.01% | 1282 |
|
|
2024
Q2 | $179K | Sell |
25,021
-2,847
| -10% | -$20.4K | ﹤0.01% | 1265 |
|
|
2024
Q1 | $242K | Buy |
27,868
+548
| +2% | +$4.75K | 0.01% | 1029 |
|
|
2023
Q4 | $179K | Buy |
27,320
+2,320
| +9% | +$15.2K | ﹤0.01% | 999 |
|
|
2023
Q3 | $250K | Sell |
25,000
-40,914
| -62% | -$409K | 0.01% | 844 |
|
|
2023
Q2 | $819K | Buy |
+65,914
| New | +$819K | 0.02% | 375 |
|
|
2021
Q2 | – | Sell |
-5,690
| Closed | -$203K | – | 1206 |
|
|
2021
Q1 | $203K | Buy |
+5,690
| New | +$203K | 0.01% | 754 |
|